Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

An investigation into the use of an extended lipid panel in the screening of cardiovascular events

View through CrossRef
ABSTRACT Introduction: Low-density lipoprotein (LDL) is classified into many subclasses based on its atherogenic propensity, with small dense (sd) LDL being a highly important risk biomarker for early coronary heart disease (CHD). Nonhigh-density lipoprotein cholesterol (non-HDLc) is made up of all atherogenic apolipoprotein B-containing lipoproteins, including low-density lipoprotein cholesterol, very-low-density lipoprotein-C, intermediate-density lipoprotein-C, lipoprotein (a), chylomicrons, and chylomicron remnants. Apolipoproteins, which include apolipoprotein B and apolipoprotein A1, are cholesterol transporters that play a key role in lipid metabolism. Furthermore, Apo-B and Apo-A1 indicate total atherogenic and nonatherogenic particles, respectively. Materials and Methods: This case–control research was done on participants visiting the cardiology and medicine OP in SRM Medical College Hospital and Research Center. The research included 546 people ranging in age from 30 to 55 years. After an overnight fast, blood samples were obtained for the measurement of apolipoprotein-B and apolipoprotein-A1 using the enzyme-linked immunosorbent assay technique. The calculation was used to determine the sd-LDL, non-HDL, and Apo-B/Apo-A1 ratios. Results: When compared to controls, the CHD group had significantly higher levels of sd-LDL, non-HDL, apolipoproteins, and the Apo-B/Apo-A1 ratio. In contrast, the mean level of LDL in CHD was higher and statistically significant (P < 0.001) when compared to normal healthy controls. Conclusion: The study shows that there is a high correlation between sd-LDL, nonHDL-C, apolipoproteins, and their Apo-B/Apo-A1 ratio. When compared to standard lipid indicators, the estimate of all of these parameters appears to be a better marker in predicting the early risk of cardiovascular disease in both diabetic and nondiabetic CHD participants and might be utilized successfully in clinical practice.
Title: An investigation into the use of an extended lipid panel in the screening of cardiovascular events
Description:
ABSTRACT Introduction: Low-density lipoprotein (LDL) is classified into many subclasses based on its atherogenic propensity, with small dense (sd) LDL being a highly important risk biomarker for early coronary heart disease (CHD).
Nonhigh-density lipoprotein cholesterol (non-HDLc) is made up of all atherogenic apolipoprotein B-containing lipoproteins, including low-density lipoprotein cholesterol, very-low-density lipoprotein-C, intermediate-density lipoprotein-C, lipoprotein (a), chylomicrons, and chylomicron remnants.
Apolipoproteins, which include apolipoprotein B and apolipoprotein A1, are cholesterol transporters that play a key role in lipid metabolism.
Furthermore, Apo-B and Apo-A1 indicate total atherogenic and nonatherogenic particles, respectively.
Materials and Methods: This case–control research was done on participants visiting the cardiology and medicine OP in SRM Medical College Hospital and Research Center.
The research included 546 people ranging in age from 30 to 55 years.
After an overnight fast, blood samples were obtained for the measurement of apolipoprotein-B and apolipoprotein-A1 using the enzyme-linked immunosorbent assay technique.
The calculation was used to determine the sd-LDL, non-HDL, and Apo-B/Apo-A1 ratios.
Results: When compared to controls, the CHD group had significantly higher levels of sd-LDL, non-HDL, apolipoproteins, and the Apo-B/Apo-A1 ratio.
In contrast, the mean level of LDL in CHD was higher and statistically significant (P < 0.
001) when compared to normal healthy controls.
Conclusion: The study shows that there is a high correlation between sd-LDL, nonHDL-C, apolipoproteins, and their Apo-B/Apo-A1 ratio.
When compared to standard lipid indicators, the estimate of all of these parameters appears to be a better marker in predicting the early risk of cardiovascular disease in both diabetic and nondiabetic CHD participants and might be utilized successfully in clinical practice.

Related Results

Lung cancer screening on YouTube: Difficulty of finding balanced information.
Lung cancer screening on YouTube: Difficulty of finding balanced information.
162 Background: Lung cancer (LC) is the leading cause of cancer mortality in the US, the ACS estimates upwards of 220,000 new cases will be diagnosed this year. Recently, the Cent...
Abstract 4154: Cancer cells exhibit novel metabolic vulnerabilities when exposed to low lipid environments
Abstract 4154: Cancer cells exhibit novel metabolic vulnerabilities when exposed to low lipid environments
Abstract Cancer cell metabolism is significantly influenced by microenvironmental factors such as nutrient availability, which can vary across different tissues and ...
Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis
Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis
BackgroundDespite a remarkable progress in the reduction of global rate of maternal mortality, cervical cancer has been identified as the leading cause of maternal morbidity and mo...
Association between dog and cat ownership with cardiovascular disease: A systematic review and meta-analysis
Association between dog and cat ownership with cardiovascular disease: A systematic review and meta-analysis
Background: Numerous studies have described the correlation of pet ownership with cardiovascular diseases, with dog and cat ownership emerging as the predominant forms of pet compa...
Patient harm from cardiovascular medications
Patient harm from cardiovascular medications
Background Medication harm can lead to hospital admission, prolonged hospital stay and poor patient outcomes. Reducing medication harm is a priority for healthc...

Back to Top